BioNTech SE (BNTX) EBIT Margin (2018 - 2026)
BioNTech SE (BNTX) reported EBIT Margin of -897.82% for Q2 2026, down 705.68 percentage points from -192.14% a year earlier and down 324.16 percentage points from the prior quarter.
Powered by 
Analysis
BioNTech SE (BNTX) EBIT Margin (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BioNTech SE's EBIT Margin came in at -75.20%, down 44.53 percentage points year-over-year; for FY2025, it came in at -48.95%, down 1.18 percentage points from FY2024.
- EBIT Margin has declined for four consecutive years, with a five-year change of -31.87 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at -47.77% in FY2024 (-65.85 pp), 18.08% in FY2023 (-54.96 pp), 73.03% in FY2022 (-7.51 pp) and 80.54% in FY2021 (+97.62 pp).
- The Q2 2026 figure ranks as the lowest quarterly EBIT Margin in data going back to Q3 2018.
- Year over year, EBIT Margin has now declined in each of the last four quarters, with an average year-over-year change of -66.60 percentage points over the last eight quarters.
- The high point for year-over-year EBIT Margin in five years was Q2 2025 (a gain of 558.60 percentage points); the low point was Q2 2026 (a drop of 705.68 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -573.67% (Q1 2026), -35.57% (Q4 2025) and -3.09% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | BioNTech SE | 25.06 Bn | -34.31 Bn | 10.00 Mn | -897.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -897.82% |
| Mar 31, 2026 | -573.67% |
| Dec 31, 2025 | -35.57% |
| Sep 30, 2025 | -3.09% |
| Jun 30, 2025 | -192.14% |
| Mar 31, 2025 | -292.18% |
| Dec 31, 2024 | 12.49% |
| Sep 30, 2024 | 0.84% |
| Jun 30, 2024 | -750.74% |
| Mar 31, 2024 | -270.36% |
| Dec 31, 2023 | 35.58% |
| Sep 30, 2023 | 8.16% |
| Jun 30, 2023 | -335.90% |
| Mar 31, 2023 | 51.25% |
| Dec 31, 2022 | 76.97% |
| Sep 30, 2022 | 68.98% |
| Jun 30, 2022 | 69.13% |
| Mar 31, 2022 | 74.56% |
| Dec 31, 2021 | 84.95% |
| Sep 30, 2021 | 77.60% |
API Access
BioNTech SE EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();